Tianxin Yang, MD, PhD
Research Interests
- Renal Physiology
- Hypertension, Renal
Languages
- English
Academic Information
- Departments: Internal Medicine - Professor, Nutrition and Integrative Physiology - Adjunct Professor
- Divisions: Nephrology
Academic Office Information
- 801-585-5570
-
School of Medicine
Nephrology
30 N 1900 E, Room: 4R312
Salt Lake City, UT 84132
Education History
Type | School | Degree |
---|---|---|
Doctoral Training | Tokyo Medical and Dental University Nephrology |
Ph.D. |
Postdoctoral Fellowship | University of Michigan Nephrology |
Postdoctoral Fellow |
Residency | Peking Union Medical College Nephrology |
Resident |
Professional Medical | Sun Yat-sen University of Medical Sciences Nephrology |
M.D. |
Global Impact
Education History
Type | School | Degree | Country |
---|---|---|---|
Doctoral Training | Tokyo Medical and Dental University Nephrology |
Ph.D. | Japan |
Residency | Peking Union Medical College Nephrology |
Resident | China |
Professional Medical | Sun Yat-sen University of Medical Sciences Nephrology |
M.D. | China |
Selected Publications
Patent
- Yang T (2019). The use of nitrated lipids for treatment of side effects of toxic medical therapy. U.S. Patent No. Serial# 61/073,945. Washington, D.C.:U.S. Patent and Trademark Office.
- Yang T (2019). The use of nitrated lipids for treatment of obesity and obesity-related conditions. U.S. Patent No. Serial# 61/046,008. Washington, D.C.:U.S. Patent and Trademark Office.
- Yang T (2019). The use of prostaglandin E inhibitors for the treatment of the side effects of a toxic medical therapy. U.S. Patent No. Serial# 083404-0160. Washington, D.C.:U.S. Patent and Trademark Office.
- Yang T (2019). Methods for treatment of inflammatory diseases. U.S. Patent No. 61/089354. Washington, D.C.:U.S. Patent and Trademark Office.
- T. Yang (2016). Use of urinary (Pro)renin receptor as biomaker of kidney disease. U.S. Patent No. 62/095949. Washington, D.C.:U.S. Patent and Trademark Office.
- T. Yang (2016). Combination therapy with nitrated lipids and inhibitors of the renin-angiotension-aldosterone system (licensed to Complexa). U.S. Patent No. 61/525,543. Washington, D.C.:U.S. Patent and Trademark Office.
- T. Yang (2016). Compositions and methods of use for (pro)renin receptor antagonists. U.S. Patent No. 14-449,714. Washington, D.C.:U.S. Patent and Trademark Office.